This is a list of selected publications.
A complete publication list can be found

Glioma research
  1. Erdem-Eraslan L, van den Bent MJ, Hoogstrate Y, Naz-Khan H, Stubbs A, van der Spek P, Böttcher R, Gao Y, de Wit M, Taal W, Oosterkamp HM, Walenkamp A, Beerepoot LV, Hanse MCJ, Buter J, Honkoop AH, van der Holt B, Vernhout RM, Sillevis Smitt PAE, Kros JM, French PJ. Identification of patients with recurrent glioblastoma who may benefit from combined bevacizumab and CCNU therapy, a report from the BELOB trial. Cancer Res (2016) 76(3):525-34
  2. Erdem-Eraslan L, Gravendeel LA, de Rooi J, Eilers PHC, Idbaih A, Spliet WGM, den Dunnen WFA, Teepen JL, Wesseling P, Sillevis Smitt PAE, Kros JM, Gorlia T, van den Bent MJ, French PJ. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. J. Clin Oncol, (2013) 31:328-36 [IF 2011: 18.4]
  3. Draaisma K, Chatzipli A, Taphoorn M, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer R, Watts C, McAbee J, Angelopoulos N, Gorlia T, Golfinopoulos V, Kros JM, Verhaak RGW, Bours V, van den Bent MJ, McDermott U, Robe PA, French PJ. Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study. J Clin Oncol. 2019 Nov 19:JCO1900367. doi: 10.1200/JCO.19.00367. 
  4. van den Bent MJ, Gravendeel LA, Gorlia T, Kros JM, Lapre L, Wesseling P, Teepen JL, Adbaih A, Sanson M, Sillevis Smitt PAE, French PJ. A Hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. Clin Can Res (2011); 17:1748-55 [IF in 2011: 7.7]
  5. Bralten LBC, Kloosterhof NK, Balvers R, Sacchetti A, Lapre L, Lamfers M, Leenstra S, de Jonge HR, Kros JM, Jansen EEW, Struys EA, Jakobs C, Salomons GS, Diks SH, Peppelenbosch M, Kremer A, Hoogenraad CC, Sillevis Smitt PAE, French PJ. IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Ann Neurol. (2011); 69:455-63 [IF in 2011: 11.1]
  6. Kloosterhof NK, Bralten LB, French PJ, van den Bent MJ. IDH1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol. (2010); 12-83-91[IF in 2010: 17.8]
  7. Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. (2009); 69:9065-72. Epub 2009 Nov 17. [IF in 2009: 7.5] link
  8. C Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, Walter Taal, Paul M Clement, Wolfgang Wick, Alba Ariela Brandes, Jean Francais Baurain, Olivier L Chinot, Helen Wheeler, Sanjeev Gill, Matthew Griffin, Leland Rogers, Roberta Rudà, Michael Weller, Catherine McBain, Jaap Reijneveld, Roelien H Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elisabeth Lim, Filip de Vos, Paul J Mulholland, Martin J B Taphoorn, Iris de Heer, Youri Hoogstrate, Maurice de Wit, Lorenzo Boggiani, Sanne Venneker, Jan Oosting, Judith VMG Bovée, Sara Erridge, Michael A Vogelbaum, Anna K Nowak,,, Warren P Mason, Johan M Kros, Pieter Wesseling, Ken Aldape, Robert B Jenkins, Hendrikus J Dubbink, Brigitta Baumert,, Vassilis Golfinopoulos, Thierry Gorlia, Martin van den Bent and Pim J French. non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations. Acta Neuropath. (2021) Mar 19. doi: 10.1007/s00401-021-02291-6
Neuronal plasticity
  1. O'Connor V, Genin A, Davis S, Karishma KK, Doyere V, De Zeeuw CI, Sanger G, Hunt SP, Richter-Levin G, Mallet J, Laroche S, Bliss TV, French PJ. Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variants. J. Biol. Chem. (2004): 279 (16):15841-9. [IF in 2004: 6.4] pdf
  2. Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci (2001);4(3):289-96. [IF in 2001: 15.7] link
Cystic Fibrosis
  1. French PJ, van Doorninck JH, Peters RH, Verbeek E, Ameen NA, Marino CR, de Jonge HR, Bijman J, Scholte BJ. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperaturesensitive processing defect in vivo. J. Clin. Invest. 1996;98(6):1304-12. [IF in 1997: 9.7] pdf
  2. van Doorninck JH, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, Scholte BJ. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J. (1995) 14, 4403-4411 [IF in 1998: 13.2] pdf
  3. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, de Jonge HR. Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMPdependent protein kinase II. J. Biol. Chem. 270 (1995), 26626-26631 [IF in 1998: 7.2] pdf
All publications